Le Lézard
Classified in: Health
Subjects: PDT, WOM, DEI

Gynov Brings Its Women's Health Supplements to the U.S. Market


FORT LAUDERDALE, Fla., Jan. 19, 2022 /PRNewswire/ -- Gynov is an innovative health company that is focused on developing dietary supplements, particularly for underserved areas of women's health. The company's products address chronic conditions from puberty to post-menopause such as endometriosis and PolyCystic Ovary Syndrome (PCOS).

For instance, the company's popular supplement Gynositol offers key nutritional support to the female reproductive system through its hero ingredients Myo-inositol and a biologically active form of Vitamin B9 called 5-MTHF. Its complementary supplement Isitol is ideal for men looking to improve fertility chances.

Gynov was founded in Paris, France in 2016 and has seen a meteoric rise in the years since. The company currently works with partners in 23 different countries across the globe at the time of this writing.

One of the most recent additions to the brand's growing list of international markets is the United States. In 2022, Gynov officially crosses the pond and will enter the U.S. marketplace, to offer its unique, science-backed dietary supplements to an eager American audience.

The brand is likely to find success in this recent overseas venture for a variety of reasons. For example, the U.S. Department of Health and Human Services reports that 10% of American women (roughly 6.1 million individuals) struggle with infertility ? an area that Gynov addresses in spades.

In addition, chronic conditions such as Polycystic ovary syndrome (PCOS) and endometriosis are rampant in the U.S. PCOS is a health concern that is reported to also impact at least one-tenth of the female population in America. CNBC reports a similar prevalence rate for women of childbearing age around the globe who are managing endometriosis.

The struggle to properly address women's health is very real in the U.S. As is the case in so many other countries, these profound chronic concerns also largely go under the radar. They are either ignored as "normal" struggles or treated with extreme pharmaceutical or medical solutions.

Gynov offers another approach. Rooted in sound scientific research, the company's dietary supplements work to holistically support the body's natural functions, both in conjunction with other medical procedures and as its own stand-alone solution.

While women's health remains a seriously misunderstood area of health, Gynov is working hard to remedy the problem. Between chronic conditions and infertility, the French innovator is offering a medically- and scientific-focused and safe option for millions of American women.

About Gynov: Gynov was founded in France in 2016 by Pierre-Yves Mousset, MD. Gynov prides itself on using advanced scientific methods to develop high-quality, effective dietary supplements dedicated to women's health and beyond. These are created to support the efficacy of prescription drugs and help provide genuine solutions for female health concerns. For more information, please visit: https://gynov.com/.

Please direct inquiries to:
Kelley Lake
(954) 673-5443
[email protected]

SOURCE Gynov


These press releases may also interest you

at 14:30
The "Global Immunoprecipitation Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029" report has been added to  ResearchAndMarkets.com's offering. The Global Immunoprecipitation Testing Market size is estimated...

at 14:25
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and...

at 14:20
Mishe (say "mish-e"), an innovator in direct healthcare, announces the launch of Downstate's Transparent Access Plan, making SUNY Downstate Health Sciences University the first hospital system in the US to offer transparent upfront pricing for its...

at 14:12
Susan G. Komen®, the world's leading breast cancer organization commends the State Assembly's proposed funding increase of $2.5 million for the Cancer Services Program (CSP) in the FY2025 Budget....

at 14:00
Neuroscientists have established in recent decades the idea that some of each day's experiences are converted by the brain into permanent memories during sleep the same night. Now, a new study proposes a mechanism that determines which memories are...

at 14:00
While traditional diaper rash creams are thick, sticky, and messy, Taro's new bébé Bottoms Diaper Rash Crème Spray allows for easy, one-handed application of a gentle spray formula that is touch-free with no rubbing needed. The light spray, which...



News published on and distributed by: